dizocilpine-maleate and metaphit

dizocilpine-maleate has been researched along with metaphit* in 2 studies

Other Studies

2 other study(ies) available for dizocilpine-maleate and metaphit

ArticleYear
Phencyclidine binds to blood platelets with high affinity and specifically inhibits their activation by adrenaline.
    The Biochemical journal, 1992, Jul-01, Volume: 285 ( Pt 1)

    The ion channel probe phencyclidine [1-(1-phenylcyclohexyl)piperidine; PCP] selectively inhibited aggregation, secretion and ultrastructural changes in platelets induced by adrenaline, but did not affect activation induced by other common platelet agonists such as alpha-thrombin, ADP, collagen or ionophore A23187. [3H]PCP bound to platelets with high affinity (Kd 134 +/- 33 nM; 3600 +/- 1020 sites/platelet), as did the thienyl analogue [3H]TCP (1-[1-(2-thienyl)cyclohexyl]piperidine). PCP binding to platelets was increased 3-4-fold in N-methylglucamine buffer in the absence of Na+ ions. Binding was unaffected by haloperidol and was only weakly inhibited (EC50 10-20 microM), without significant stereoselectivity by the two sets of stereoselective ligands, dexoxadrol/levoxadrol and (+)MK801/(-)MK801. Binding of PCP was not competed for by adrenaline or yohimbine. Only the high-affinity binding of [3H]PCP to platelets was blocked by prior treatment of the platelets with the covalent affinity probe Metaphit, and these platelets no longer aggregated in response to adrenaline although they responded normally to alpha-thrombin, ADP and collagen. These results suggest that platelets contain high-affinity receptors for PCP that can modulate adrenaline-induced platelet activation.

    Topics: Binding, Competitive; Blood Platelets; Cells, Cultured; Chromatography, Gel; Cyclic AMP; Dioxolanes; Dizocilpine Maleate; Epinephrine; Humans; Phencyclidine; Piperidines; Platelet Activation; Receptors, Neurotransmitter; Receptors, Phencyclidine

1992
Metaphit fails to antagonize PCP-induced passive avoidance deficit.
    Pharmacology, biochemistry, and behavior, 1991, Volume: 38, Issue:1

    Pretreatment with metaphit (1-[1-(3-isothiocyanotophenyl)cyclohexyl]piperidine), a putative irreversible antagonist of phencyclidine (PCP) receptors, did not antagonize PCP-induced passive avoidance deficit in rats, and did not decrease [3H]MK-801 (5-methyl-10,11-dihydro-5H-dibenzocyclohepten-5,10-imine maleate) binding to PCP recognition sites coupled to NMDA receptors. The effectiveness of the metaphit treatment was evidenced by the occurrence of audiogenic seizures. These results suggest that previously reported antagonism in vivo actions of PCP by metaphit, is mediated by sites not involved in PCP-induced passive avoidance deficit, and not related to the NMDA receptor complex in brain structures studied (striatum, hippocampus, and cortex).

    Topics: Animals; Avoidance Learning; Dizocilpine Maleate; In Vitro Techniques; Kinetics; Male; Phencyclidine; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Synaptic Membranes

1991